|Bid||1.61 x 1100|
|Ask||1.62 x 2500|
|Day's Range||1.61 - 1.68|
|52 Week Range||1.35 - 8.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 6, 2018 - Mar 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.79|
The San Diego firm said net product sales of Ingrezza, a treatment for tardive dyskinesia, were $45.8 million during the quarter. The FDA approved Ingrezza in April.
CHESTERBROOK, Pa., Nov. 02, 2017-- Trevena, Inc. today announced that it has recently submitted its New Drug Application for OLINVO TM to the U.S. OLINVO is the first G protein biased ligand of the mu ...
CHESTERBROOK, Pa., Nov. 01, 2017-- Trevena, Inc. today announced that it will host a conference call and webcast on Tuesday, November 7, 2017 at 8:00 am EST to review financial results for the quarter ...
Chester County biopharmaceutical company Trevena Inc. is cutting 21 jobs and halting its investments in early-stage research under a restructuring to focus its resources on its lead new drug candidate. The workforce reduction represents 30 percent of the Chesterbook, Pa., company's staff. Trevena's immediate focus will be on the potential approval and commercialization of Olinvo, its new drug candidate under development as a potential treatment to manage moderate-to-severe acute pain.
–Initiative streamlines operations to focus on approval and commercial launch of OLINVO™ and significantly reduces operating expenses–. –New Drug Application for OLINVO remains on track for submission ...
CHESTERBROOK, Pa., Sept. 22, 2017-- Trevena, Inc. today announced that it will be presenting at the 3rd Annual 2017 Healthcare Conference hosted by Ladenburg Thalmann on Tuesday, September 26, 2017, at ...
The King Of Prussia, Pennsylvania-based company said it had a loss of 35 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...
The King Of Prussia, Pennsylvania-based company said it had a loss of 36 cents per share. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Trevena, Inc. Here are 5 ETFs with the largest exposure to TRVN-US. Comparing the performance and risk of Trevena, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)